NCT04928144View on ClinicalTrials.gov

Phase 1 Study of SHJ002 Sterile Ophthalmic Solution in Pediatric Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 2, 2021

Primary Completion Date

September 17, 2021

Study Completion Date

September 17, 2021

Conditions
Myopia
Interventions
DRUG

SHJ - Low concentration

Topical ophthalmic

DRUG

SHJ - Mid concentration

Topical ophthalmic

DRUG

SHJ - High concentration

Topical ophthalmic

DRUG

SHJ - Maximum tolerated

SHJ - Maximum tolerated

Trial Locations (1)

Unknown

Kaohsiung Veterans General Hospital, Kaohsiung City

All Listed Sponsors
lead

Sunhawk Vision Biotech, Inc.

INDUSTRY